Quotes: US MENA   Enter Symbol: NewsLetter: Search: advanced

Promethera(R)Biosciences welcomes Frank Hazevoets as chief financial officer  Join our daily free Newsletter

MENAFN Press - 13/05/2014
No. of Ratings : 0
Add to Mixx!



(MENAFN Press) Promethera(R) Biosciences, an innovative orphan drug therapy company that develops stem cell therapies for the treatment of liver diseases, today announces that Frank Hazevoets has joined the company to lead its finance and administration team. Frank joined Promethera Biosciences SA on May 1, 2014 as chief financial officer (CFO). He will be based at the head office in Mont-Saint-Guibert, Belgium.

Frank Hazevoets is a highly experienced senior financial executive with over twenty five years international business experience. He trained at the Catholic University of Leuven (KUL) in Belgium as a commercial engineer and also obtained a masters degree in Artificial Intelligence and Cognitive Science. He has worked in leading positions in corporate finance and investment banking, strategy and business development. During his six years as CFO at Tigenix, he supported the company in its funding and growth strategy and helped them to obtain the first European marketing authorization for cell-based medicinal products in Europe.

"We are delighted that Frank is joining Promethera Biosciences as CFO," said Eric Halioua, chief executive officer. "He is going to play a key role in assisting our future development. Frank Hazevoets has the experience and expertise to strengthen the management team and to prepare the next strategic options at Promethera Biosciences. He will build the finance department to further support the future growth of Promethera(R)."

"I am really looking forward to working with the experienced team at Promethera and to sharing my expertise with them," said Frank Hazevoets, chief financial officer of Promethera Biosciences. "This company has the potential to become one of the leading orphan drug companies in the world. Many patients will benefit from their lead in developing and commercializing innovative cell and orphan therapy products based on proprietary technologies."

About Promethera Biosciences:

Promethera Biosciences is a pharmaceutical company that develops innovative therapies for the treatment of orphan liver diseases. It is currently developing two products based on human liver progenitor cells:

Promethera(R) HepaStem is a cell therapy product based on the use of allogeneic stem cells isolated from healthy adult human livers (Heterologous Human Adult Liver Progenitor Cells, HHALPC). These cells can be used to treat a wide variety of liver diseases, from rare inborn metabolic diseases (which can be classified as 'orphan diseases' and mainly affecting children), to acquired deficiencies affecting adults, such as acute-on chronic liver diseases or liver fibrosis. HepaStem is currently tested in phase I/II clinical trial in Europe and Israel for the treatment of two orphan indications.

Promethera(R) H2Screen and H3Screen is a non-therapeutic in vitro product, based on a recently discovered and patented liver progenitor cell type, isolated from healthy adult human livers. This novel biotechnology tool is designed for early preclinical pharmaco-toxicological evaluation of drug candidates and new chemical entities.

Promethera Biosciences is a spin-off of the Universite Catholique de Louvain (UCL), founded in 2009. The company emerged from the lab of Professor Etienne Sokal, a leading expert in pediatric liver disease and cell. Promethera Biosciences is located in Mont-Saint-Guibert (Belgium).

Since its creation in 2009, Promethera Biosciences has raised EUR 34 million in two financial rounds, in capital, grants and loans from the Walloon Region. The main investors are Vesalius Biocapital, Mitsui Global Investment, BI Venture Fund, Shire and SRIW.

Promethera Biosciences has 47 employees led by an experienced management team.

For more information, please visit http://www.promethera.com


About Promethera(R)
Promethera(R)

 






  MENA News Headlines
 Aug 21 2014 - Ebola virus disease West Africaupdate 8 August 2014 E-mail PrintMENAFN Press
(MENAFN Press) GENEVA Switzerland August 8 2014/African Press Organization (APO)/ -- Epidemiology and surveillance Between 5 and 6 August 2014 a total of 68 new cases of Ebola virus disease ...

 Aug 21 2014 - Nina Duong Haute Couture Announces Relocation From Toronto to Oakville OntarioExtravagant Wedding Gowns For Exceptional BridesMENAFN Press
(MENAFN Press) Nina Duong collections are as breathtaking as they are luxurious. All gowns are hand-sewn using the most exquisite fabrics especially fine silks from around the world.OAKVILLE ...

 Aug 21 2014 - Asry signs USD8.6m desalination plant contractMENAFN
(MENAFN) Asry, the leading ship and rig repair yard in the Gulf, agreed a build-operate-transfer (BOT) contract for the completion and upgrading of a reverse osmosis seawater desalination plant, Gulf ...

 Aug 21 2014 - Generational Diversity Expert Dr. Chip Espinoza Completes Seminal Work MillennialsWorkMENAFN Press
(MENAFN Press) It is no secret that young adults commonly referred to as Millennials grew up in a culture radically different from those of the generations that preceded them. Not only were ...

 Aug 21 2014 - Hamas warns foreign airlines as Israel declares talks overArab News
(MENAFN - Arab News) GAZA CITY Palestinian Territories: The armed wing of Hamas warned foreign airlines against flying into Tel Aviv on Wednesday and declared truce talks in Cairo over as a six-week ...

 Aug 21 2014 - Saudi- Iconic Urdu poet in Jeddah for mushairaArab News
(MENAFN - Arab News) Some of the most-loved names in Urdu poetry will regale hundreds of expatriates with their couplets at the Indian Consulate's annual mushaira to be held at the International ...

 Aug 21 2014 - Saudi- PISJ-ES reports outstanding academic featArab News
(MENAFN - Arab News) Students of the Pakistan International School-Jeddah (English Section) (PISJ-ES) have shown outstanding academic performance this year.According to the school's acting principal ...

 Aug 21 2014 - 77000 Saudi youth aspire for skilled jobsArab News
(MENAFN - Arab News) With only three days left for submitting applications around 77000 Saudi men and women have enrolled for vocational training at the Colleges of Excellence (CoE) throughout the ...

 Aug 21 2014 - Saudi- Woman ordered to pay SR30000 for khulaArab News
(MENAFN - Arab News) A court in Riyadh has ordered a woman to pay SR30000 for her to be able to separate from her husband after he injected her with a narcotic substance local media said.The man in ...

 Aug 21 2014 - Saudi- Shoura member to speak at world science conferenceArab News
(MENAFN - Arab News) A leading Swiss scientific foundation has chosen a female Saudi Shoura Council member to speak alongside international personalities at a conference highlighting the role of ...

more...


 






Google

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country

IPO News
Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices

US Markets Details

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Investment Game
Economic Calendar
Financial Glossary

My MENAFN
Portfolio Tracker

Voting

Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2000 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help